PHARMACYTE BIOTECH, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
PHARMACYTE BIOTECH, INC. (PMCB) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 279.80 thousand shares as of 2023-10-31, per its 10-Q filed 2023-12-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2023-12-15
- 2023-10-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 279.80K shares.
- 2023-07-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 280.94K shares.
- 2023-04-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 281.27K shares.
- 2023-01-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 281.94K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2023-10-31 | 279.80K shares 10-Q · filed 2023-12-15 |
| 2023-07-31 | 280.94K shares 10-Q · filed 2023-09-18 |
| 2023-04-30 | 281.27K shares 10-K · filed 2023-07-31 |
| 2023-01-31 | 281.94K shares 10-Q · filed 2023-03-16 |
| 2022-10-31 | 37.60K shares 10-Q · filed 2022-12-14 |
| 2022-07-31 | 35.77K shares 10-Q · filed 2022-09-14 |
| 2022-04-30 | 36.90K shares 10-K · filed 2022-07-28 |
| 2022-01-31 | 43.17K shares 10-Q · filed 2022-03-15 |
| 2018-04-30 | 88.05M shares 10-K · filed 2018-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |